This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Structures and Propagation of Pathologically Relevant Amyloids in Alzheimers. Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
PERK as a central mediator of neurotoxicity in tauopathies Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Endocannabinoids in Neurodegenerative Diseases Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Defining the role of FUS phosphorylation in neurodegeneration Investments > €500k United States of America Alzheimer’s disease & other dementias|Motor neurone diseases 2016
Biological and Pathological Interactions between Tau and LRRK2 Investments > €500k United States of America Alzheimer’s disease & other dementias|Parkinson’s disease & PD-related disorders 2016
Circadian dysfunction and GSK3 in neurodegenerative disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
GGGGCC hexanucleotide repeat expansions in neurodegenerative disease Investments > €500k United States of America Alzheimer’s disease & other dementias|Motor neurone diseases 2016
Preclinical Diagnostic Imaging of Amyloid Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Silencing C9or72 with rAAV Mediated RNAi Investments > €500k United States of America Alzheimer’s disease & other dementias|Motor neurone diseases 2016
Tau-mediated regulation of axonal transport Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
